Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 700 shares at $8.52 ($6K) on 2007-04-23, disclosed to the SEC on 2007-04-25.
Scheduled sale ($6k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.52 | 100 | $852 | 14.2% |
| 2 | $8.53 | 100 | $853 | 14.2% |
| 3 | $8.54 | 100 | $854 | 14.2% |
| 4 | $8.59 | 100 | $859 | 14.3% |
| 5 | $8.61 | 100 | $861 | 14.3% |
| 6 | $8.62 | 100 |
| $862 |
| 14.4% |
| 7 | $8.65 | 100 | $865 | 14.4% |
| Total | $8.58 avg | 700 | $6K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |